Skip to main content

Table 1 Baseline characteristics of the cohort with univariate analysis of risk factors for detection of complicated hospitalization

From: Elevated red cell distribution width predicts poor outcome in young patients with community acquired pneumonia

Characteristic

 

NT (%)

NUC (%)

NC (%)

Odds ratio (95% CI)

P value

  

637

466 (73.2)

171 (26.8)

  

Gender

Male

403 (63.3)

282 (60.5)

121 (70.8)

1.58 (1.082-2.305)

0.018

 

Female

234 (36.7)

184 (39.5)

50 (29.2)

Reference

1.000

Age (years)

≤30

126 (19.8)

106 (27)

20 (11.7)

Reference

 
 

31-40

136 (21.4)

97 (29.2)

39 (22.8)

2.13 (1.163-3.904)

0.014

 

41-50

144 (22.6)

109 (30.9)

35 (20.5)

1.70 (0.924-3.135)

0.088

 

51-60

231 (36.3)

154 (49.6)

77 (45.0)

2.65 (1.528-4.596)

0.001

Co-morbid conditions

Malignancy

60 (9.4%)

32 (6.9)

28 (16.4)

2.66 (1.546-4.563)

<0.0001

Prior neurologic damage

125 (19.6%)

57 (12.2)

68 (39.8)

4.74 (3.134-7.160)

<0.0001

Chronic renal failure

26 (4.1%)

15 (3.2)

11 (6.4)

2.07 (0.930-4.594)

0.075

Heart disease

56 (8.8%)

34 (7.3)

22 (12.9)

1.88 (1.063-3.310)

0.030

Lung disease*

193 (30.3%)

128 (27.5)

65 (38)

1.61 (1.115-2.337)

0.011

Asthma

41 (6.4%)

35 (7.5)

6 (3.5)

0.45 (0.185-1.084)

0.075

Chronic obstructive lung disease

77 (12.1%)

50 (10.7)

27 (15.8)

1.56 (0.941-2.585)

0.084

Lung malignancy

37 (5.8%)

20 (4.3)

17 (9.9)

2.46 (1.257-4.820)

0.009

Post chest radiation

31 (4.9%)

14 (3)

17 (9.9)

2.96 (1.074-8.146)

0.036

Immune deficiency

156 (24.5%)

98 )21)

58 (33.9)

1.93 (1.309-2.839)

0.001

Hematologic malignancy

45 (7.1%)

30 (6.4)

15 (8.8)

2.38 (0.944-5.982)

0.066

Corticosteroid therapy

76 (11.9%)

44 (9.4)

32 (18.7)

2.21 (1.347-3.619)

0.002

Nursing institution

52 (8.2%)

21 (4.5)

31 (18.1)

4.69 (2.612-8.427)

<0.0001

SBP on admission (mmHg)

137.3 ± 32.1

137.9 ± 36.1

136.6 ± 29.0

1.009 (0.942-1.082)

NS

DBP on admission (mmHg)

77.4 ± 16.1

77.8 ± 18.3

76.9 ± 12.6

1.011(0.945-1.081)

NS

Heart rate on admission (min-1)

86.7 ± 20.2

86.8 ± 20.6

86.7 ± 20.1

0.998 (0.926-1.077)

NS

Laboratory parameters

BUN > 10.7 mmol/L

65 (10.2%)

35 (7.5)

30 (17.5)

2.62 (1.552-4.422)

<0.0001

Creatinine >114 μmol/L

88 (13.8%)

54 (11.6)

34 (19.9)

1.89 (1.183-3.031)

0.008

Hemoglobin <110 g/L

113 (17.7%)

68 (14.6)

45 (26.3)

2.11 (1.375-3.229)

0.001

Hematocrit <30 mg/dl

56 (8.8%)

31 (6.7)

25 (14.6)

2.42 (1.383-4.233)

0.002

Glucose >13.8 mmol/L

39 (6.1%)

24 (5.2)

15 (8.8%)

1.77 (0.903-3.454)

0.096

WBC <4 or >12 × 109/L

347 (54.5%)

238 (51.1)

109 (63.7)

1.68 (1.174-2.416)

0.005

RDW >14.5%

218 (34.2%)

123 (26.4)

95 (55.6)

3.49 (2.419-5.023)

<0.0001

  1. P < 0.05 represents significant statistical difference between patients with complicated and uncomplicated hospitalization
  2. BUN, blood urea nitrogen; CI, confidence interval; DBP, diastolic blood pressure; NC, number of complicated admissions; ns, not significant; NT, all the patients that were included in the cohort; NUC, number of uncomplicated admissions as defined; RDW, red cell width distribution; SBP, systolic blood pressure; WBC, white blood cells.
  3. * Includes bronchial asthma, chronic obstructive lung disease, interstitial lung disease, bronchiectasis, permanent tracheostomy, lung malignancy, past history of thoracic radiotherapy, previous episode of pneumonia, and previous or current active smoking.